HIGHLIGHTS
- who: Jiwei Cheng and Guoyi Li from the Spectrum Health, United States University of North Carolina at Chapel have published the article: Safety and efficacy of low-dose and long-course tirofiban in large hemispheric infarction, in the Journal: (JOURNAL)
- what: The aim of this study was to explore the efficacy and safety of low-dose and long-course tirofiban in the treatment of acute LHI to provide a clinical reference. The patients included in this study had similar baseline NIHSS scores. The analysis showed that tirofiban did not increase the risk of non-intracranial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.